Skip to main content
Top

2010 | OriginalPaper | Hoofdstuk

2 Ziekte van Lyme

Auteur : Mevr. dr. A.A.M. Blaauw

Gepubliceerd in: Het Reumatologie & Orthopedie Formularium

Uitgeverij: Bohn Stafleu van Loghum

share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Samenvatting

De ziekte van Lyme is een infectieziekte, veroorzaakt door de spirocheet Borrelia burgdorferi (B. burgdorferi), die wordt overgedragen door een beet van een teek, Ixodes ricinus.
Literatuur
1.
go back to reference Boon S van den, Pelt W van. Verdubbeling consulten voor tekenbeten en Lyme ziekte. Onderzoek in de huisartspraktijk: 1994 en 2001. Infectieziektenbulletin. 2003;5:162-163. Boon S van den, Pelt W van. Verdubbeling consulten voor tekenbeten en Lyme ziekte. Onderzoek in de huisartspraktijk: 1994 en 2001. Infectieziektenbulletin. 2003;5:162-163.
2.
go back to reference Berglund J, Eitrem R, Ornstein K, et al. An epidemiological study of Lyme disease in southern Sweden. N Engl J Med. 1995;333:1319-1327.PubMedCrossRef Berglund J, Eitrem R, Ornstein K, et al. An epidemiological study of Lyme disease in southern Sweden. N Engl J Med. 1995;333:1319-1327.PubMedCrossRef
3.
go back to reference Steere AC, Schoen RT, Taylor E. The clinical evolution of Lyme Arthritis. Ann Intern Med. 1987;107:725-731.PubMedCrossRef Steere AC, Schoen RT, Taylor E. The clinical evolution of Lyme Arthritis. Ann Intern Med. 1987;107:725-731.PubMedCrossRef
4.
go back to reference Luger SW, Paparone P, Wormser GP, et al. Comparison of Cefuroxime Axetil and Doxycycline in treatment of patients with early Lyme disease associated with erythema migrans. Antimicrob Agents Chemother. 1995;39:661-667.PubMedCentralPubMedCrossRef Luger SW, Paparone P, Wormser GP, et al. Comparison of Cefuroxime Axetil and Doxycycline in treatment of patients with early Lyme disease associated with erythema migrans. Antimicrob Agents Chemother. 1995;39:661-667.PubMedCentralPubMedCrossRef
5.
go back to reference Gerber MA, Shapiro ED, Burke GS, et al. Lyme disease in children in southeastern Connecticut. Pediatric Lyme Disease Study Group. N Engl J Med. 1996;335:1270-1274.PubMedCrossRef Gerber MA, Shapiro ED, Burke GS, et al. Lyme disease in children in southeastern Connecticut. Pediatric Lyme Disease Study Group. N Engl J Med. 1996;335:1270-1274.PubMedCrossRef
6.
go back to reference Blaauw AAM, Nohlmans MKE, Leffers P, et al. Lyme borreliosis: a very infrequent cause of arthritis of undetermined etiology in the southern part of The Netherlands. Br J Rheumatology. 1992;31:401-404.CrossRef Blaauw AAM, Nohlmans MKE, Leffers P, et al. Lyme borreliosis: a very infrequent cause of arthritis of undetermined etiology in the southern part of The Netherlands. Br J Rheumatology. 1992;31:401-404.CrossRef
7.
go back to reference Berglund J, Blomberg I, Hansen BU. Lyme borreliosis in rheumatological practice: identification of Lyme arthritis and diagnostics aspects in a Swedish county with high endemicity. Br J Rheumatology. 1996;35:853-860.CrossRef Berglund J, Blomberg I, Hansen BU. Lyme borreliosis in rheumatological practice: identification of Lyme arthritis and diagnostics aspects in a Swedish county with high endemicity. Br J Rheumatology. 1996;35:853-860.CrossRef
8.
go back to reference Blaauw AAM, Dijkmans BAC, Bouma PAD, et al. Rational diagnosis and treatment in unclassified arthritis: how clinical data may guide requests for Lyme serology and antibiotic treatment. Ann Rheum Dis. 1993;52:206-210.PubMedCentralPubMedCrossRef Blaauw AAM, Dijkmans BAC, Bouma PAD, et al. Rational diagnosis and treatment in unclassified arthritis: how clinical data may guide requests for Lyme serology and antibiotic treatment. Ann Rheum Dis. 1993;52:206-210.PubMedCentralPubMedCrossRef
9.
go back to reference Wilske B. Microbiological diagnosis in Lyme Borreliosis. Int J Med Microbiol. 2002;291(S33):114-119.PubMedCrossRef Wilske B. Microbiological diagnosis in Lyme Borreliosis. Int J Med Microbiol. 2002;291(S33):114-119.PubMedCrossRef
10.
go back to reference Bunikis J, Barbour AG. Laboratory testing for suspected Lyme Disease. Med Clin North Am. 2002;86(2):311-340.PubMedCrossRef Bunikis J, Barbour AG. Laboratory testing for suspected Lyme Disease. Med Clin North Am. 2002;86(2):311-340.PubMedCrossRef
11.
go back to reference Kuiper H, Cairo I, Dam A van, et al. Solitary erythema migrans: a clinical, laboratory and epidemiological study of 77 Dutch patients. Br J Dermatol. 1994;130:466-472.PubMedCrossRef Kuiper H, Cairo I, Dam A van, et al. Solitary erythema migrans: a clinical, laboratory and epidemiological study of 77 Dutch patients. Br J Dermatol. 1994;130:466-472.PubMedCrossRef
12.
go back to reference Speelman P. Is het zinvol om bij een tekenbeet preventief eenmalig doxycycline 200 mg oraal te geven om besmetting met Borrelia burgdorferi te voorkomen? Ned Tijdschr Geneeskd. 2007;151:1901.PubMed Speelman P. Is het zinvol om bij een tekenbeet preventief eenmalig doxycycline 200 mg oraal te geven om besmetting met Borrelia burgdorferi te voorkomen? Ned Tijdschr Geneeskd. 2007;151:1901.PubMed
13.
14.
go back to reference Steere AC, Levin RE, Molloy PJ, et al. Treatment of Lyme arthritis. Arthritis Rheum. 1994;37:878-888.PubMedCrossRef Steere AC, Levin RE, Molloy PJ, et al. Treatment of Lyme arthritis. Arthritis Rheum. 1994;37:878-888.PubMedCrossRef
15.
go back to reference Steere AC, Angelis AM. Therapy for Lyme arthritis. Arthritis Rheum. 2006;10:3079-3086.CrossRef Steere AC, Angelis AM. Therapy for Lyme arthritis. Arthritis Rheum. 2006;10:3079-3086.CrossRef
16.
go back to reference Hassler D, Zoller L, Haude M, et al. Cefotaxime versus penicillin in the late stage of Lyme disease-prospective, randomised therapeutic study. Infection. 1990;18:16-20.PubMedCrossRef Hassler D, Zoller L, Haude M, et al. Cefotaxime versus penicillin in the late stage of Lyme disease-prospective, randomised therapeutic study. Infection. 1990;18:16-20.PubMedCrossRef
17.
go back to reference Bentas W, Karch H, Huppertz HI. Lyme arthritis in children and adolescents: outcome 12 months after initiation of antibiotic therapy. J Rheumatol. 2000;27:27:2025-2030.PubMed Bentas W, Karch H, Huppertz HI. Lyme arthritis in children and adolescents: outcome 12 months after initiation of antibiotic therapy. J Rheumatol. 2000;27:27:2025-2030.PubMed
19.
go back to reference Klempner MS, Hu LT, Evans J, et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med. 2001;345:85-92.PubMedCrossRef Klempner MS, Hu LT, Evans J, et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med. 2001;345:85-92.PubMedCrossRef
20.
go back to reference Feder HM, Johnson BJB, O’Connell S, et al. A criticial appraisal of ‘‘Chronic Lyme Disease’’. N Engl J Med. 2007;357:1422-1430.PubMedCrossRef Feder HM, Johnson BJB, O’Connell S, et al. A criticial appraisal of ‘‘Chronic Lyme Disease’’. N Engl J Med. 2007;357:1422-1430.PubMedCrossRef
21.
go back to reference Speelman P, Jongh BM de, Wolfs TF, et al. Richtlijn Lyme-borreliose. Ned Tijdschr Geneeskd. 2004;148:659-663.PubMed Speelman P, Jongh BM de, Wolfs TF, et al. Richtlijn Lyme-borreliose. Ned Tijdschr Geneeskd. 2004;148:659-663.PubMed
Metagegevens
Titel
2 Ziekte van Lyme
Auteur
Mevr. dr. A.A.M. Blaauw
Copyright
2010
Uitgeverij
Bohn Stafleu van Loghum
DOI
https://doi.org/10.1007/978-90-313-8192-0_2